These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9527796)

  • 21. Studies of the killing kinetics of benzylpenicillin, cefuroxime, azithromycin, and sparfloxacin on bacteria in the postantibiotic phase.
    Odenholt I; Löwdin E; Cars O
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2522-6. PubMed ID: 9371360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of subinhibitory concentrations of moxifloxacin in an in-vitro dynamic model.
    Maggiolo F; Capra R; Bartoli A; Bottura P; Migliorino M; Suter F
    J Chemother; 2000 Apr; 12(2):129-33. PubMed ID: 10789551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target.
    Andes D; Craig WA
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1376-83. PubMed ID: 16569855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postexposure factors influencing the duration of postantibiotic effect: significance of temperature, pH, cations, and oxygen tension.
    Fuursted K
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1693-6. PubMed ID: 9257743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo pharmacokinetics and pharmacodynamics of the lantibiotic NAI-107 in a neutropenic murine thigh infection model.
    Lepak AJ; Marchillo K; Craig WA; Andes DR
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1258-64. PubMed ID: 25512404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-antibacterial effect of thymol.
    Zarrini G; Delgosha ZB; Moghaddam KM; Shahverdi AR
    Pharm Biol; 2010 Jun; 48(6):633-6. PubMed ID: 20645735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of sub-minimal inhibitory concentrations of aspoxicillin in prolonging the postantibiotic effect against Staphylococcus aureus.
    Oshida T; Onta T; Nakanishi N; Matsushita T; Yamaguchi T
    J Antimicrob Chemother; 1990 Jul; 26(1):29-38. PubMed ID: 2211444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postantibiotic effect of sanfetrinem compared with those of six other agents against 12 penicillin-susceptible and -resistant pneumococci.
    Spangler SK; Lin G; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2173-6. PubMed ID: 9333043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postantibiotic effects of eleven antimicrobials on five bacteria.
    Wang MG; Zhang YY; Zhu DM; Zhang J; Shi YG
    Acta Pharmacol Sin; 2001 Sep; 22(9):804-8. PubMed ID: 11749860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Duration and clinical relevance of postantibiotic effect in relation to the dosing interval.
    den Hollander JG; Fuursted K; Verbrugh HA; Mouton JW
    Antimicrob Agents Chemother; 1998 Apr; 42(4):749-54. PubMed ID: 9559777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacodynamics of cefquinome in a neutropenic mouse thigh model of Staphylococcus aureus infection.
    Wang J; Shan Q; Ding H; Liang C; Zeng Z
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3008-12. PubMed ID: 24614373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postantibiotic effects of imipenem, norfloxacin, and amikacin in vitro and in vivo.
    Renneberg J; Walder M
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1714-20. PubMed ID: 2511798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro evaluation of CBR-2092, a novel rifamycin-quinolone hybrid antibiotic: microbiology profiling studies with staphylococci and streptococci.
    Robertson GT; Bonventre EJ; Doyle TB; Du Q; Duncan L; Morris TW; Roche ED; Yan D; Lynch AS
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2324-34. PubMed ID: 18443106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postantibiotic and sub-MIC effects of benzylpenicillin against Streptococcus pneumoniae with different susceptibilities for penicillin.
    Odenholt I; Gustafsson I; Löwdin E
    Chemotherapy; 2003 Dec; 49(6):287-93. PubMed ID: 14671428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Combination effect of vancomycin and cefpirome against methicillin-resistant Staphylococcus aureus in vitro--antimicrobial activities in postantibiotic phase].
    Hasegawa H; Kanai A; Otoguro K; Shimizu K
    Kansenshogaku Zasshi; 1996 Feb; 70(2):151-60. PubMed ID: 8851387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo postantibiotic effect in a thigh infection in neutropenic mice.
    Vogelman B; Gudmundsson S; Turnidge J; Leggett J; Craig WA
    J Infect Dis; 1988 Feb; 157(2):287-98. PubMed ID: 3121761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo pharmacodynamics of a new oxazolidinone (linezolid).
    Andes D; van Ogtrop ML; Peng J; Craig WA
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3484-9. PubMed ID: 12384354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacodynamics of beta-lactam antibiotics. Studies on the paradoxical and postantibiotic effects in vitro and in an animal model.
    Odenholt-Tornqvist I
    Scand J Infect Dis Suppl; 1989; 58():1-55. PubMed ID: 2499924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postantibiotic effect of ceftaroline against gram-positive organisms.
    Pankuch GA; Appelbaum PC
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4537-9. PubMed ID: 19770288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postantibiotic effects and postantibiotic sub-MIC effects of tilmicosin, erythromycin and tiamulin on erythromycin-resistant Streptococcus suis.
    Wang L; Zhang Y
    Braz J Microbiol; 2009 Oct; 40(4):980-7. PubMed ID: 24031450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.